KLDO — Kaleido Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Kaleido Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	28.5	76.1	71.2	46.2	38.5
Net Total Receivables	0.045	0.005	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	28.6	76.2	73.3	48.7	42.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.98	4.69	6.74	8.46	5.67
Other Long Term Assets
Total Assets	30.7	85.3	82.3	59.3	50.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.85	11.3	10.4	16.7	29.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21.9	28.3	33.4	38.8	39.5
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	8.81	57	48.9	20.5	10.6
Total Liabilities & Shareholders' Equity	30.7	85.3	82.3	59.3	50.1
Total Common Shares Outstanding